-Bloomberg
Morgan Stanley Maintains Equal-Weight on GoHealth, Lowers Price Target to $13
Morgan Stanley analyst Lauren Schenk maintains GoHealth (NASDAQ:GOCO) with a Equal-Weight and lowers the price target from $14 to $13.
Related Posts
Pandemic Hits Nathan’s Q4 Earnings; Still Maintains Quarterly Dividend
Nathan’s Famous Inc (NASDAQ:NATH) reported fourth-quarter FY21 sales of $18.28 million, down 15.76% year-on-year. FY21 sales were $75.83 million, a 26%…
Conformis Shares Shoot Higher Following FDA Clearance For Actera Hip System
Conformis (NASDAQ: CFMS) has received 510(k) clearance from the U.S. Food and Drug Administration for its Actera Hip System.
Actera utilizes an advanced tri-taper femur stem design that facilitates direct anterior approach total hip arthroplasties, and provides an additional stem option to orthopedic surgeons.
Green Thumb Partners With Mental Health Co. To Address Veterans’ Issues, Stem Suicides
Cannabis company Green Thumb Industries (OTCQX: GTBIF) announced that it has teamed up with peer-based mental health company Happy to directly address the mental health of U.S. military veterans.